Patient centric drug analysis platform

Abstract

The present disclosure relates to a patient centric system and platform that enables a customized analysis of a patient's health conditions for assessing appropriateness of an ordered treatment. In one aspect, patient centric analysis platform includes memory having computer-readable instructions stored therein and one or more processors. The one or more processors configured to execute the computer-readable instructions to receive, from a terminal, patient identifying information of a patient; receive, from the terminal, an initial treatment order for the patient; retrieve patient specific information and treatment specific information; generate a numerical assessment of the initial treatment order based on the patient specific information and the treatment specific information, the numerical assessment indicating a safety level of the initial treatment order; and communicate the numerical assessment to the terminal.

What is claimed is: 
     
         1 . A patient centric analysis platform comprising:
 memory having computer-readable instructions stored therein; and   one or more processors configured to execute the computer-readable instructions to:
 receive, from a terminal, patient identifying information of a patient; 
 receive, from the terminal, an initial treatment order for the patient; 
 retrieve patient specific information and treatment specific information; 
 generate a numerical assessment of the initial treatment order based on the patient specific information and the treatment specific information, the numerical assessment indicating a safety level of the initial treatment order; and 
 communicate the numerical assessment to the terminal. 
   
     
     
         2 . The patient centric analysis platform of  claim 1 , wherein the one or more processors are configured to execute the computer-readable instructions to:
 determine a plurality of distinct numerical values for a plurality of distinct patient and treatment scores; and   generate the numerical assessment based on the plurality of distinct numerical scores.   
     
     
         3 . The patient centric analysis platform of  claim 2 , wherein the one or more processors are configured to execute the computer-readable instructions to add the plurality of distinct numerical scores to generate the numerical assessment. 
     
     
         4 . The patient centric analysis platform of  claim 2 , wherein the plurality of distinct patient and treatment scores include:
 a medication score;   a therapeutic duplication score;   a metabolic interaction score;   a drug-disease contraindication score;   a drug to drug interaction score;   a renal functionality score;   a pregnancy score;   an allergy score;   a serum creatinine score;   a duration score;   an adverse reaction score; and   a medication abuse/misuse score.   
     
     
         5 . The patient centric analysis platform of  claim 1 , wherein the one or more processors are configured to execute the computer-readable instructions to determine whether the numerical assessment indicates that the initial treatment order is safe. 
     
     
         6 . The patient centric analysis platform of  claim 5 , wherein, when the numerical assessment indicates that the initial treatment order is not safe, the one or more processors are configured to execute the computer-readable instructions to communicate with the terminal to adjust the initial treatment order such that an updated numerical assessment would be safe. 
     
     
         7 . The patient centric analysis platform of  claim 5 , wherein the one or more processors are configured to execute the computer-readable instructions to recommend an adjustment to the initial treatment order when the numerical assessment indicates that the initial treatment order is not safe. 
     
     
         8 . The patient centric analysis platform of  claim 1 , wherein the one or more processors are configured to execute the computer-readable instructions to receive a login request and authorize access to the patient centric administration platform prior to receiving the patient identifying information. 
     
     
         9 . The patient centric analysis platform of  claim 1 , wherein the one or more processors are configured to communicate, with the numerical assessment, a detailed report on patient specific medical history and conditions and current medication usage of the patient. 
     
     
         10 . A patient centric analysis method comprising:
 receiving, from a terminal, patient identifying information of a patient;   receiving, from the terminal, an initial treatment order for the patient;   retrieving patient specific information and treatment specific information;   generating a numerical assessment of the initial treatment order based on the patient specific information and the treatment specific information, the numerical assessment indicating a safety level of the initial treatment order; and   communicate the numerical assessment to the terminal.   
     
     
         11 . The patient centric analysis method of  claim 10 , further comprising:
 determining a plurality of distinct numerical values for a plurality of distinct patient and treatment scores; and   generating the numerical assessment based on the plurality of distinct numerical scores.   
     
     
         12 . The patient centric analysis method of  claim 11 , wherein the numerical assessment is generated by adding the plurality of distinct numerical scores to generate the numerical assessment. 
     
     
         13 . The patient centric analysis method of  claim 11 , wherein the plurality of distinct patient and treatment scores include:
 a medication score;   a therapeutic duplication score;   a metabolic interaction score;   a drug-disease contraindication score;   a drug to drug interaction score;   a renal functionality score;   a pregnancy score;   an allergy score;   a serum creatinine score;   a duration score;   an adverse reaction score; and   a medication abuse/misuse score.   
     
     
         14 . The patient centric analysis method of  claim 10 , wherein, when the numerical assessment indicates that the initial treatment order is not safe, the method comprises recommending an adjustment to the initial treatment orders when the numerical assessment indicates that the initial treatment orders is not safe. 
     
     
         15 . The patient centric analysis method of  claim 10 , further comprising:
 receiving a login request; and   authorizing access to a patient centric administration platform prior to receiving the patient identifying information.   
     
     
         16 . The patient centric analysis method of  claim 10 , wherein the treatment is a medication. 
     
     
         17 . One or more non-transitory computer-readable media having computer-readable instructions stored thereon, which when executed by one or more processors, cause the one or more processors to:
 receive, from a terminal, patient identifying information of a patient;   receive, from the terminal, an initial treatment order for the patient;   retrieve patient specific information and treatment specific information;   generate a numerical assessment of the initial treatment order based on the patient specific information and the treatment specific information, the numerical assessment indicating a safety level of the initial treatment order; and   communicate the numerical assessment to the terminal.   
     
     
         18 . The one or more non-transitory computer-readable media of  claim 17 , wherein the execution of the computer-readable instructions further cause the one or more processors to:
 determine a plurality of distinct numerical values for a plurality of distinct patient and treatment scores; and   generate the numerical assessment based on the plurality of distinct numerical scores.   
     
     
         19 . The one or more non-transitory computer-readable media of  claim 18 , wherein the execution of the computer-readable instructions further cause the one or more processors to add the plurality of distinct numerical scores to generate the numerical assessment. 
     
     
         20 . The one or more non-transitory computer-readable media of  claim 18 , wherein the plurality of distinct patient and treatment scores include:
 a medication score;   a therapeutic duplication score;   a metabolic interaction score;   a drug-disease contraindication score;   a drug to drug interaction score;   a renal functionality score;   a pregnancy score;   an allergy score;   a serum creatinine score;   a duration score;   an adverse reaction score; and   a medication abuse/misuse score.